Patients with advanced skin cancer to test a new vaccine in NHS drive
Patients with advanced skin cancer will be able to test a new vaccine as part of a drive to speed up the development of new treatments.
The NHS Cancer Vaccine Launch Pad (CVLP) intends to accelerate access to messenger ribonucleic acid (mRNA) vaccine clinical trials for people with different types of cancer.
The programme has already given thousands of patients better access to a personalised vaccine for bowel cancer, and is now expanding to include a trial for melanoma.
The CVLP aims to provide up to 10,000 patients in England with personalised cancer treatments in the UK by 2030.
Faster recruitment to the trials and having them run in more NHS sites means they should be able to progress faster and produce results more quickly.
The new melanoma vaccine, known as iSCIB1+ (Immunobody), helps the immune system recognise cancer cells and therefore better respond to existing immunotherapy treatment.
By working to help the body recognise, attack and 'remember' cancer cells, it can help stop the disease returning.
Around half of melanoma patients respond to immunotherapy, but those who do not are at higher risk of their cancer getting worse.
The vaccine is being trialled by needle-free injection into the skin or muscle, and the CVLP, working with UK life-sciences company Scancell, hopes to expand the number of patients taking part by October.
Melanoma is the fifth most common cancer in the UK, accounting for around 4% of all new cancer cases.
NHS national cancer director, Professor Peter Johnson, said: 'Skin cancer can have a devastating impact and we know that cancer vaccines have the potential to revolutionise cancer care for patients in this country and across the world – and to save more lives.
'It's incredibly exciting that the NHS is expanding its world-leading programme so more patients with different types of cancer could benefit from the development of new vaccines that could stop their cancer coming back.'
Grandfather-of-four Paul Thomas, 63, from New Milton, Hampshire, was first diagnosed with advanced skin cancer in 2017, and the disease kept returning following treatment.
Last year, Mr Thomas, who owns a window cleaning business, was given the opportunity to be part of the SCOPE skin cancer vaccine trial which is now part of the NHS CVLP.
He said: 'I feel so lucky to be put on the trial. Thankfully I was still quite fit and since I've been on it, my tumours have all shrunk.
'Every time I go for a scan they seem to be shrinking, which is really exciting.
'I'm really hoping for total eradication of my cancer, as opposed to being put in remission, and I'm feeling optimistic.
'The care I've had so far has been fantastic and the team that have looked after me have been superb, along with amazing support from my family, I'm so thankful.'
Dr Nermeen Varawalla, chief medical officer, Scancell, said: 'Cancer vaccines have the potential to transform immunotherapy, redefine treatment options and ultimately save lives.
'Recent clinical data has demonstrated that our potent, tumour-targeted 'off-the-shelf' cancer vaccine delivers strong efficacy, with the potential for meaningful long-term survival benefits in patients with advanced metastatic melanoma.
'Our partnership with the CVLP will give patients expedited access to this landmark study and is an important step in accelerating the clinical development of this important new treatment.'
Susanna Daniels, chief executive of Melanoma Focus, said: 'Melanoma skin cancer can be deadly and it's sadly on the rise in the UK.
'As well as continuing to call for urgent action on prevention, we're delighted to see progress in innovative treatments and very much welcome the expansion of this vaccine trial.
'The use of vaccines to treat melanoma is an exciting development and we will be encouraging eligible patients to take part in these ground-breaking trials with our up-to-date Melanoma TrialFinder so that vaccines can be understood and patients can locate trial centres to discuss with their medical teams.'
Prime Minister Sir Keir Starmer said: 'This kind of innovation is nothing short of life-saving and I want to see more of these world-leading treatments being developed in the UK.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
‘My border terrier Tilly helped me survive the grief of losing my son'
In life's darkest moments, comfort can come from the strangest of places. For Mike Clarke, coming to terms with the sudden and tragic death of his 29-year-old son Nick to Melanoma cancer, that lifeline came in the form of a beautiful border terrier named Tilly. Mike admits he had always been 'more of a cat person' and the decision to get a dog was not one which he initially wanted. But like many parents, Mike and his wife of 40 years Mandy, both 62, eventually gave in to the pleading from their son, who was set to return home from university to live with his parents in Whitley Bay to begin teaching. But Nick's plans changed after he completed a final university placement at a primary school in Newham – where they liked him so much he was offered a job. Nick accepted the position, and dedicated himself to the school, where, over more than seven years, he played a key role alongside his colleagues in helping it to achieve an 'Outstanding' rating from Ofsted. Nick had been successfully treated for melanoma in 2018, after it had developed from a mole on his side. But during the height of lockdown in late 2020, the cancer returned without anyone realising. On a Zoom call in December, Mike noticed his son looked unwell. Trusting his instincts, he took matters into his own hands. 'There was an emphasis on not putting a strain on the NHS, so he couldn't get access to the hospital in London,' Mike says. 'We just thought he might have a side effect of Covid so I drove down to London to take him back home and get him checked out there. I've had cancer myself, so when I picked him up and saw how he looked, in my mind I knew he had cancer again.' Mike drove Nick straight to their local hospital, in Cramlington, where they kept him overnight. Nick ended up in critical care, where due to Covid restrictions, Mike and Mandy couldn't visit him. When it became clear that his condition was deteriorating, Nick made the decision to return home that Saturday, where he tragically passed away the following evening among family and friends. It was a devastating time. Mike says of his son: 'He is never far from my mind, he was a deeply kind, well-natured boy. Everybody loved him, he had so many friends.' The intense pain of losing a loved one can make grief an incredibly lonely experience, especially when you feel nobody can understand the emotions you are going through. Mike says that in the days and weeks after losing Nick, he found the non-negotiable routine of walking Tilly was crucial in stopping him and Mandy from isolating from the world. 'Having to walk the dog was fundamental in making me face reality. It would've been very easy to just shut the outside world out, but you couldn't do that because Tilly needed walking. 'In the weeks following Nick's passing we were out with her a lot, she was our coping mechanism in that respect.' He adds: 'Even if you wanted to lie in bed, you couldn't because you've got a dependent member of the family who needs looking after. It's similar to having to care for a child, but I found it incredibly helpful as it gave me a focus and forced us to get fresh air.' Those daily dog walks also helped Mike keep in touch with familiar faces – and he also credits Tilly with helping him return to his former job at Natwest. 'You see the same people day in and day out, because everyone's out walking at the same time. That really helped as it got me used to being around people again, which prepared me for facing colleagues at work.' Making new friends as an adult can be difficult, but Tilly's dog walks had already led to Mike meeting new people who became a crucial support. 'I've made a close circle of friends through Tilly who've been instrumental in helping my grieving process,' he says. 'We call ourselves the Dog Dad Curry Club and we go out for drinks together and curry nights which has provided me with a social outlet I didn't have before Tilly. Going through grief makes you learn who your friends really are, and these friends have supported and looked after me through everything. 'At Nick's funeral we could only have 12 close family and friends in, so the Dog Dad Curry Club lined up outside the funeral amongst hundreds of others to honour Nick's memory and support us. Over the years they have never shied away from talking with me about my grief.' Mike insists that he couldn't have made such a supportive social group without Tilly: 'I never would've met them without morning walks on the beach. We support each other because we have this common interest in the love we have for our dogs.' Tilly's now aged 13, and Mike says he won't be rushing to get another dog when the time comes. After everything she's helped him through, the idea of replacing her doesn't sit right. 'Mandy and I are terrified of losing her because she's still a link with Nick. She's been our crutch,' he says. 'We wouldn't replace her without Nick as we wouldn't have someone to take care of her if we were away, and we want to travel more as Nick loved to. So certainly, when the inevitable comes, I don't envisage getting another dog straight away.' For Mike, it's not just about losing a dog, it's about losing a companion which carried him and his wife through their darkest days. 'When life felt so unstable, it was nice to have somebody who was just constantly there. You know dogs, they just love you, they don't cause any problems. 'Tilly has helped us to process grief and brought us to peace with the outside world.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
27 minutes ago
- Yahoo
Weight-loss jabs may need to be taken for life, experts warn
Weight-loss jabs may have to be used for many years if the long-term benefits to patients and the NHS are to be realised, experts have said. The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings. Obese patients can currently be prescribed the jabs on the NHS after being referred to specialist weight loss clinics, which are usually located in hospitals. Hundreds of thousands of people also access the medication privately at pharmacies. There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support. Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise. Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about. 'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies. 'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS. 'There's no point in most people taking it for a couple of years and then have the weight bouncing back. 'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense. 'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected. 'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further. 'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.' Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year. 'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said. 'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs. 'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs. 'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was. 'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.' Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone. Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle. 'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said. 'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that. 'But we should absolutely all be looking at our diet and all changing our diet, and doing something.' Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions. 'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said. 'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out. 'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work. 'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease. 'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.' Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them. 'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said. 'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified. 'If you do find those side-effects, you can stop taking the drug.'
Yahoo
5 hours ago
- Yahoo
'Nurses emailed us praising our hand cream — it was rocket fuel for us'
Jonny and Antonia Philp have already endured enough personal and business challenges to last a career since co-founding Nursem, their range of hand and bodycare products, in 2012. The husband and wife team have claimed universal credit and turned down a Dragons' Den offer, while Jonny has overcome a brain tumour. It has since left him to live by the mantra of 'look after yourself, your health and have fun'. From turning over around £50,000 in their early years, Nursem hit public awareness in 2019 and now anticipate sales of £2.7m this year, with aims of growing their word-of-mouth business tenfold. Read More: How Caroline's Circuits became a midlife fitness empire The company launched in response to a problem encountered by Jonny's wife Antonia as an NHS paediatric nurse, working on intensive care wards and washing her hands between 50 and 100 times daily. After six months, her hands started to crack and bleed with the demands of work. The Philps realised she wasn't the only one, with nearly 90% of the nursing community suffering similar issue, despite trying a raft of hand creams. 'Hand cream sounds like an incredibly simple solution, probably overly simple, but sometimes the best solutions are the simplest because people know how to adopt and use them properly,' says Jonny. Originally called Yes Nurse – 'It was like a Carry On film,' admits Jonny – he paid himself £500 for the first five years alongside Antonia's salary. 'Until children,' he adds. 'That's when things become a lot more real.' He describes the feeling of juggling jobcentre meetings as the co-founders 'tried to survive for six months until we could launch into Boots in time". 'I think the lady looked at me and thought, 'this guy's on another planet'," he adds. "This is not the usual person she would expect to be interviewing. But I'm enormously grateful because, without it, there's no way we could have paid for nursery in those first months.' Read More: 'Why we set up a sustainable mobile operator to save people money' Back at the day job, he says that emails from nurses a decade ago were like 'rocket fuel' for a fledgling business. 'Nurses would say that it's the first time in 25 years that their hands weren't painful at work. Messages like that were like a shot in the arm and kept us going," says Jonny. Newcastle-based Nursem recorded sales of £142,000 (a net loss of £18,000) in their first year before a rebrand and relaunch in 2019 and COVID saw the company grow from a run rate of £150,000 per annum to £2.5m in 18 months. In 2020, Nursem's Caring hand cream was featured on ITV's This Morning. A product was sold every 36 seconds for several weeks while Boots also experienced empty shelves for a period. The publicity saw increased awareness of the company's 'Nursem Promise' where, for every product sold, they donate a month's worth to an NHS nurse or midwife. In 2021, the duo also appeared on Dragons' Den and received offers from all five before later rejecting a stake. This all pales into significance to January 2016 when Jonny was told by a consultant that he had an acoustic neuroma, a brain tumour on the left-hand side of his head. The couple had only been married three months. 'I lived on £500 a month, had enough money to fill the car up and buy some groceries. I was quite happy,' he admits. Read More: Meet the company that finds 'must-haves' to make everyday life easier 'It made me realise that all the dreams you have about building a business were just dreams up until that point. I was going to have to stick my head above the parapet.' Every year, Jonny paused for reflection when undergoing an MRI scan. The tumour was later removed in 2022 and three months of recovery followed. 'It took us 18 months of graft to get us back on track,' he adds. Nursem, says Jonny, is still largely a kitchen table, remote-first business, which employs 13 staff. The business is now driving demand from chefs, florists, mechanics and hairdressers. 'It is the shift towards people who are looking for something that's incredibly effective and cracking on with the rest of the day,' adds Jonny. 'It's the same for nurses in that you can't sit around for 10 minutes waiting for your hand cream to dry when it's a busy day.' A specialist transplant liaison nurse, Antonia has now joined the business full-time but will still be a registered nurse. 'We've got three kids and ambitions to grow 10x, but this means we can look after each other and be more present,' adds Jonny. The Nursem Promise If we were going to move the brand into retail on a bigger scale, how do we keep our heart and soul in the nursing community? That's when we realised rather than selling it to nurses, we should be providing it for free to deliver the biggest impact. For some nurses it can be absolutely debilitating and painful while at work. Not all hospitals provide access to moisturisers for staff so we decided to try and tackle it ourselves as a brand. We hear every single day from healthcare professionals how much it helps them. How to be a start-up success It's very easy to get distracted and move into other categories. The way we see the future is to continue to look after hands and become incredibly well known for doing one thing well. My key advice to other budding start-ups would be that if you're going to invest your time and energy, make sure you're tackling something that is a genuine issue that people have and that it affects enough people as well. Obsess over whatever the solution is that you're looking to launch, whether it's a physical product or a service. Think about all the key hurdles to get past and be absolutely brutally honest with yourself and actually work back from that goal. It will make life 10 times easier. Read more: Meet the 'jokers from London' who sold 100,000 blocks of butter in first 10 weeks 'My sofa took six months to arrive — so I built a £20m business' 'I paid myself £4 an hour to get my Rollr deodorant off the ground'
